THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE BLANKET PURCHASE AGGRENMENT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES . The Defense Health Agency Contracting Activity (DHACA), Western Healthcare Operations Contracting Division (WHCO-CD), Echo Branch intends to negotiate and award a Blanket Purchase Agreement (BPA) with a 5 year ordering period that provides firm-fixed priced orders for cost-per-test (CPT) reagents chemistry analyzer and consumable supplies utilized by 374th Medical Group (MDG) at Yokota Air Base, Japan in accordance with Federal Acquisition Regulation (FAR) 13.501(a) Sole Source acquisitions and FAR 13.106-1(b)(1)(i), only one source being available to meet the Government’s needs, to: ORTHO CLINICAL DIAGNOSTICS.K.K. GATE CITY OSAKI EAST TOWER 16F 1-11-2, OSAKI, SHINAGAWA-KU TOKYO, JAPAN 141-0032 PH: 0120-03-6527 SAM UEI: E35NFBSEY3X4 The North American Industry Classification System (NAICS) code for this requirement is 334516, Analytical Laboratory Instrument Manufacturing ; the business size standard is 1,000 (in number of employees). The Product Service Code (PSC) is 6630 - Chemical Analysis Instruments . The objective of this sole source BPA is to establish a 5-year ordering period for CPT reagents supply delivery and consumables to provide testing with an inclusion of a lease of Chemistry and Immunoassay Testing System (VITROS 7600), and maintenance support at 374th Medical Group (MDG), Laboratory Department. More details can be found in the Statement of Work (SOW) under “Attachments”. BPA Ordering Period: 1 July 2024 to 30 June 2029 Delivery location: 374th Medical Group (MDG) Attention: Clinical Laboratory Building 4408 Unit 5071 Yokota Air Base, Japan, 96328-5071 Based on market research and previous acquisition history, it has been determined that Ortho Clinical Diagnostics, K.K.., is the only source that can meet the Government’s minimum requirements to provide the CPT testing compatible with the installed equipment to 374th MDG without requiring extensive validation time resulting in significant disruption to patient care. This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the requirement in accordance with the Statement of Work (SOW) under “Attachments”. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to
[email protected]. The closing date for challenges is no later than 12:00 p.m. Pacific Time on 24 April 2024. NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.